Non-muscle myosin II is an important component of the cytoskeleton, playing a major role in cell motility and chemotaxis. We have previously demonstrated that, on stimulation with epidermal growth factor (EGF), non-muscle heavy chain myosin II-B (NMHC-IIB) undergoes a transient phosphorylation correlating with its cellular localization. We also showed that members of the protein kinase C (PKC) family are involved in this phosphorylation. Here we demonstrate that of the two conventional PKC isoforms expressed by prostate cancer cells, PKC βII and PKCγ, PKCγ directly phosphorylates NMHC-IIB. Overexpression of wild-type and kinase dead dominant negative PKCγ result in both altered NMHC-IIB phosphorylation and subcellular localization. We have also mapped the phosphorylation sites of PKCγ on NMHC-IIB. Conversion of the PKCγ phosphorylation sites to alanine residues, reduces the EGF-dependent NMHC-IIB phosphorylation. Aspartate substitution of these sites reduces NMHC-IIB localization into cytoskeleton. These results indicate that PKCγ regulates NMHC-IIB phosphorylation and cellular localization in response to EGF stimulation.
Introduction
Directed cell migration is a complex process; it requires numerous factors to coordinate the functioning of the cell cytoskeleton so that the cell achieves the necessary polarization for chemotaxis (Lauffenburger and Horwitz, 1996; Mitchison and Cramer, 1996) . One of the cytoskeletal proteins that plays an important role in chemotaxis is non-muscle myosin II (Spudich, 1989; Chung et al., 2001; Postma et al., 2004) . In vertebrates, there are at least three non-muscle myosin II heavy chain (NMHC) genes that encode separate isoforms of the heavy chain: NMHC-IIA, NMHC-IIB and NMHC-IIC (Katsuragawa et al., 1989; Kawamoto and Adelstein, 1991; Golomb et al., 2004) . These myosin II isoforms differ in their heavy chain sequences (Takahashi et al., 1992; Golomb et al., 2004) , in the kinetics of ATPase activity (Kelley et al., 1996; Kovacs et al., 2003; Rosenfeld et al., 2003; Wang et al., 2003; De La Cruz and Ostap, 2004; Kim et al., 2005) and in their subcellular localization in various cells types (Maupin et al., 1994; Kelley et al., 1996; Kolega, 1998 Kolega, , 2003 Bao et al., 2005; Kim et al., 2005) . Myosin II is a hexamer composed of two heavy chains of ~200 kDa and two pairs of 17 and 20 kDa light chains, and it is regulated by light chain and heavy chain phosphorylation (Tan et al., 1992; Bresnick, 1999; de la Roche and Cote, 2001) . Phosphorylation of the regulatory light chains regulates the actin-activated ATPase activity and filament assembly (Bresnick, 1999) . Phosphorylation of myosin II heavy chains in the slime mold Dictyostelium discodeum inhibits filament assembly (Kuczmarski and Spudich, 1980; Pasternak et al., 1989; Liang et al., 1999) . In addition, a number of myosin II heavy chain kinases (NMHCKs), purified from Dictyostelium cells, regulate the assembly properties of myosin II heavy chains in vivo (de la Roche and Cote, 2001 ). However, the mechanisms controlling myosin II heavy chain phosphorylation in mammalian cells are still largely unknown.
In vitro and in vivo studies have shown that heavy chains of NMHC-IIA and NMHC-IIB are phosphorylated by a number of kinases, including protein kinase C (PKC) and casein kinase II (CKII) (Kawamoto et al., 1989; Ludowyke et al., 1989; Murakami et al., 1990; Conti et al., 1991; Kelley et al., 1991; Moussavi et al., 1993; Murakami et al., 1995; Murakami et al., 1998; Straussman et al., 2001) . However, there is still a controversy about the effect of heavy chain phosphorylation on filament assembly of NMHC-IIA and NMHC-IIB. Murakami et al. reported that heavy chain phosphorylation by PKC and CKII inhibits filament assembly of NMHC-IIB but not of NMHC-IIA. In contrast, filament assembly of NMHC-IIA is regulated by non-covalent association of Mts1 protein (Murakami et al., 1995; Murakami et al., 1998; Murakami et al., 2000) . Recently, however, filament assembly of NMHC-IIA was shown to be regulated by both heavy chain phosphorylation and by Mts1 (Li et al., 2003; Dulyaninova et al., 2005) . Thus, the regulation of NMHC-II by heavy chain phosphorylation remains unclear.
We have shown previously that EGF stimulation of prostate metastatic cells (TSU-pr1 cells) transiently increases phosphorylation of both NMHC-IIA and NMHC-IIB. However, only NMHC-IIB phosphorylation correlated with the EGF-dependent dynamics of the distribution of NMHC-IIB between the cytoplasm and the cell cortex (Straussman et al., 2001 ).
This phosphorylation is carried out by member(s) of the PKC family (Straussman et al., 2001 ).
In addition, over-expression of a short fragment derived from the carboxyl terminus of NMHC-IIB, which can undergo phosphorylation but is unable to form filaments, abolished the EGFdependent NMHC-IIB phosphorylation, thus significantly increasing the amount of NMHC-IIB in the cell cortex (Ben-Ya'acov and Ravid, 2003) . These findings were explained by the NMHC-IIB fragment competing with the endogenous NMHC-IIB for the heavy chain kinase(s), resulting in impaired heavy chain phosphorylation and localization.
The experiments presented here provide evidence that PKCγ directly phosphorylates NMHC-IIB in vitro. Furthermore, over-expression of PKCγ wild-type or dominant-negative kinase-dead PKCγ affects NMHC-IIB phosphorylation and cellular localization. Finally, NMHC-IIB with all PKCγ sites replaced by alanine residues showes reduced phosphorylation 3 in vivo. Furthermore replacing these sites with aspartate residues resulted in reduced localization of this mutated NMHC-IIB with the cell cytoskeleton both in TSU-Pr1 cells and in fibroblasts lacking NMHC II-B (Tullio et al., 1997) . To our knowledge, this is the first demonstration that an NMHC-IIB kinase in mammalian cells regulates NMHC-IIB function in vivo.
Materials and Methods

Cell lines and culture conditions
TSU-pr1 prostate carcinoma cell line, (Iizumi et al., 1987) was kindly provided by Dr. A.
Passaniti (University of Maryland, National Institute of Health, Baltimore). TSU-pr1 cells were maintained in RPMI-1640 (Sigma), supplemented with 10 % fetal calf serum and antibiotics (100 units/ml penicillin, 100 μg/ml streptomycin and 1:100 Biomyc3 antimycoplasma antibiotic solution, all from Biological Industries, Beit HaEmek, Israel). were maintained in high-glucose DMEM supplemented with 2mM L-gluthamine, 10% fetal calf serum and antibiotics (100 units/ml penicillin, 100 μg/ml streptomycin and 1:100 Biomyc3 anti-mycoplasma antibiotic solution (All from Biological Industries, Beit HaEmek, Israel).
COS-
All cell lines were grown in a humidified atmosphere of 5% CO 2 and 95% air, at 37 o C.
Kinase activity assay for recombinant PKC isoforms
Purified recombinant human PKCβII and PKCγ (Sigma) were dissolved to 20 ng/μl in dilution buffer (10 mM HEPES pH 7.4, 5mM DTT, 0.01% Triton X-100). All reactions were performed in 50 μl volume. 10 μl of substrate mix (20 mM Tris pH 7.5, 600 mM NaCl, 5 mM EDTA, 1 mM DTT and 5 μg 70kDa NMHC-IIB fragment (MHCBrod) (Ben-Ya'acov and Ravid, 2003) ) were dissolved in 28 μl 10 mM HEPES pH 7.4. To each reaction mixture 5 μl of activator mix (0.2 mg/ml 1,2-dioleoyl-sn-glycerol (Sigma), 1 mg/ml L-α-phosphatidyl-Lserine (Sigma) and 2 mM CaCl 2 in 10 mM HEPES pH 7.4) and 2 μl (40 ng) of appropriate enzyme was added. The reaction was initiated by the addition of 5 μl of ATP mix (10 mM HEPES pH 7.4, 1 mM ATP (Roche), 2.5 μCi of [γ 32 P] ATP (Amersham) and 100 mM MgCl 2 ).
After 7 min of incubation at 30°C the reactions were stopped by the addition of 100 μl ice-cold 40% trichloroacetic acid (TCA). After incubating for 10 min on ice, the precipitated proteins were pelleted for 10 min by centrifugation at 16,000 g. The pellets were washed once with 500
μl ice-cold 5% TCA and 30 μl 2x SDS-PAGE sample buffer (100mM Tris pH 6.8, 200mM
DTT, 4% SDS, 0.2% bromophenol blue, 20% glycerol), were added to the reactions and boiled for 5 min at 100°C. The samples were separated on 10% SDS-PAGE and the MHCBrod fragments were visualized by staining with Coomassie-Blue reagent. To determine the amount of phosphate incorporation, the bands of MHCBrod substrate were excised from the gel, transferred to tubes containing 3 ml scintillation liquid and counted using a scintillation counter. The specific activity for each sample was expressed as the amount of phosphate incorporated into a mole of substrate per min per μg enzyme.
Autophosphorylation of PKCγ was carried out as described above for kinase assay except that MHCBrod was not added. Kinase assays with myelin basic protein (MBP) (Sigma) were performed as described above with minor modifications. Reaction volume was 100 μl and contained 10 μg of MBP dissolved in 78 μl 20 mM HEPES pH 7.4 and 10 μl of activators mix and 2 μl (40 ng) of appropriate enzyme were added. Reaction was initiated by the addition of 10 μl of ATP mix. After incubation at 30°C for 7 min, the reactions were stopped by the addition of 150 μl ice-cold 40% TCA. After incubating for 10 min on ice, the precipitated proteins were pelleted for 10 min by centrifugation at 16,000 g. The pellets were washed once with 500 μl ice-cold 5% TCA and 30 μl 2x SDS-PAGE sample buffer were added to the pellets and boiled for 5 min at 100°C. The samples were separated on 12% SDS-PAGE, the MBP were visualized by staining with Coomassie-Blue reagent. The MBP bands excised from the gel and counted using scintillation counter. The specific activity for each sample was 6 expressed as the amount of phosphate incorporated into a mole of MBP per min per μg enzyme. 
Construction of
Construction of NMHC-IIB mutants
MHCBrod (Ben-Ya'acov and Ravid, 2003) Figure 1 .
Transfections
For transient transfection, cells were plated on 30mm or 60mm tissue culture plates 16 hours before the transfection. Transfection was performed with 1 μg or 4 μg of the plasmid DNA per 30mm or 60mm dish respectively, using JetPEI Transfection Reagent ("Polyplustransfection", Inc, Strasbourg, France) with N/P ratio = 7, according to the manufacturer's instructions. For stable transfection, 4x10 5 TSU-pr1 cells were plated on 30mm tissue culture dishes about 16 hours before the transfection. Cells were transfected with 1 μg of the plasmid DNA according to the same protocol. Stable clones were selected and isolated using 400 μg/ml G418 antibiotics (Calbiochem).
Gel electrophoresis and western blot analysis of GFP-PKCγ expression
To prepare whole cell extracts, TSU-pr1 cells stably expressing GFP-PKCγ WT or GFP-PKCγ DN were plated on 30mm tissue culture dishes and grown to 80 % confluence at 37 0 C in a humidified atmosphere. Cells were then washed once with PBS, and 100 μl 2 x SDS-PAGE sample buffer was added and the lysed cells were scraped, from the dishes, transferred to eppendorf tubes and boiled for 5 min at 100 0 C. 30 μl of whole cell extracts were separated on SDS-PAGE using Laemmli's system (Laemmli, 1970) . Western blot analysis was performed as described (Straussman et al., 2001) . Briefly, the nitrocellulose membrane was blocked with 5% for 24 hrs in high glucose DMEM supplemented with 2 mM L-gluthamine, 100 units/ml penicillin, 100 μg/ml streptomycin and 0.1% fatty-acids free bovine serum albumin (Sigma).
After starvation, cells were fixed for 10 min in 1.5 ml of 3.7 % formaldehyde in PBS and processed for imaging using a 40x objective under a Zeiss LSM 410 inverted confocal laser scanning system. Confocal images were converted to TIFF format and transferred to a Zeiss imaging workstation for pseudocolor presentation.
In vivo NMHC II-B phosphorylation in TSU-Pr1 cells
In order to measure the in vivo phosphorylation of endogenous NMHC-IIB, 1.2 x 10 6 TSU-pr1 cells expressing GFP, PKCγ WT or PKCγ DN were plated on 100 mm dishes about 18 hours before the experiment. After 2 hrs of starvation in RPMI-1640 supplemented with 100 units/ml penicillin, 100 μg/ml streptomycin and 12mM HEPES pH 7.4, cells were stimulated with 7 ng/ml EGF. After stimulation, cells were lysed in 1.5 ml of 1 x radioimmunoassay precipitation buffer (50 mM Tris pH 7.5, 1% NP-40, 0.5% deoxycholic acid, 50 mM sodium pyrophosphate, 100 mM sodium fluoride and protease inhibitors mix (Sigma)). After 10 min incubation on 4 0 C, lysed cells were scraped from the dishes, transferred to 2ml tubes and incubated 10 min on ice. Cell debris were pelleted for 15 minutes by centrifugation at 16,000 g. In vivo GFP-NMHC II-B phosphorylation in transiently transfected COS-7 cells 6 x 10 5 cells COS-7 cells were plated on 60mm tissue culture dishes 16 hrs before transfection.
6 hrs after transfection with NMHC-IIB tagged with GFP constructs, cells were re-plated on 100 mm tissue culture dishes and incubated 36 hrs at 37 0 C in humidified atmosphere. After 4 hrs starvation in high-glucose DMEM supplemented with 2 mM L-gluthamine, 100 units/ml penicillin, 100 μg/ml streptomycin and 12mM HEPES pH 7.4, cells were stimulated with 10 ng/ml EGF and lysed in 1.2 ml of 1 x radioimmunoassay precipitation buffer and protease inhibitors mix (Sigma)). After 10 min incubation on 4 0 C, lysed cells were scraped from the dishes, transferred to eppendorf tubes and incubated 10 min on ice. Cell debris were pelleted for 15 minutes by centrifugation at 16,000 g. Each lysate was incubated for 2 hrs at 4 0 C on rotary shaker with 24 μl of GFP rabbit polyclonal affinity purified antibody prepared in our laboratory. Immunocomplexes were precipitated using 60 μl of protein A-agarose (Oncogene).
After 3 washes with 500 μl of 1 x radioimmunoassay precipitation buffer, 60 μl 2x SDS-PAGE sample buffer were added and boiled for 5 min at 100 0 C. The samples were separated on 6% SDS-PAGE and stained with SilverSnap Stain Kit II (Pierce). The amount of GFP-NMHC-IIB precipitated was determined by measuring the intensity of GFP-NMHC-IIB bands using the 
Mass Spectrometry
5 μg of 18 kda NMHC II-B tail (Ben-Ya'acov and Ravid, 2003) was phosphorylated for 8 hrs using 500 ng recombinant PKCγ as described above, except for the ATP concentration in the mixture, which was 500 μM instead of 100 μM and 32 P-γATP was not present. For the non-phosphorylated reference we used the same amount of NMHC II-B tail that was incubated for 8 hrs in the same conditions except for the addition of PKCγ. The samples were separated on 12% SDS-PAGE and stained with Coomassie brilliant blue. The phosphorylated and unphosphorylated NMHC II-B tail bands were excised from the gel, reduced, alkylated and digested in-gel using sequencing-grade trypsin (Promega) as described (Pandey et al., 2000) .
The peptide mixture was desalted using ZipTip C 18 column (Millipore) and the peptides were eluted using 80% acetonitrile and 1% formic acid. The eluted peptides were directly injected by spraying capillaries (Protana) into a Q-TOF II mass spectrometer (Micromass) equipped with a nanoelectrospray source. MS and MS/MS spectra were measured using 1200 V capillary voltage and the MS/MS collision energy was 20-45 V.
MHCBrod purification and determination of critical concentration for filament assembly
Escherichia coli strain BL-21 containing the pET21c-MHCBrod wild type or MHCBrod-S6D mutant plasmid were grown to OD 600 = ~0.6 and then induced with 1 mM IPTG for 2 h. Bacteria pellets were lysed with lysis buffer (50mM Tris-HCL pH 7.5, 0.8 M NaCl, 10 mM EDTA, 10 mM EGTA, 1 mM DTT, 1 mg/ml Lysozyme and 0.5 mM PMSF) and sonicated. Sonicates were centrifuged and the proteins were precipitated from the supernatant with 10% polyethylenimine (Burgess, 1991) , centrifuged at 16,000 g and the following by boiling to denature all proteins except for the α-helical coiled-coil MHCBrod. The mixture was then centrifuged at 100,000 g and the MHCBrod and MHCBrod-S6D were precipitated from the supernatant using ammonium sulfate to remove the remnants of polyethylenimine.
The ammonium sulfate pellet was solubilized in Buffer G (20 mM Tris-HCl pH 7.5, 600 mM NaCl, 5 mM EDTA and 1 mM DTT), dialyzed against Buffer C (10 mM Tris-HCl pH 7.5, 50
mM NaCl, and 2 mM MgCl 2 ), centrifuged at 100,000 g and the precipitated proteins were resuspended in buffer G. To determine the critical concentration, the proteins were diluted to 25, 50, 100, 250 and 500 μg/ml in Buffer G. 80 μl of each protein concentration were dialyzed for 4 h in 150 mM NaCl dialysis buffer (10 mM phosphate buffer pH 7.5, 2 mM MgCl 2 and 150 mM NaCl), centrifuged in a TL-100 ultracentrifuge (Beckman) at 100,000 g, for 1 h at supplemented with 2 mM L-gluthamine, 100 units/ml penicillin, 100 μg/ml streptomycin and 0.1% fatty-acids free bovine serum albumin (Sigma). After starvation, cells were lysed by the addition of 200 μl of lysis buffer (50 mM Tris pH 7.4, 50 mM NaCl, 5 mM MgCl 2 , 1% Triton X-100 and protease inhibitors mix (Sigma)) to the plates followed by incubation for 10 min at 4°C. The Triton-soluble fractions were collected from the plates and centrifuged for 5 min at 16,000 g to remove the remnants of the insoluble fraction. 100 μl of supernatant were removed to fresh tubes and 25 μl of 5x SDS-PAGE sample buffer were added, the tubes were boiled for 5 min at 100 0 C. After addition of 120 μl SDS-PAGE sample buffer to the plates, the insoluble fractions, were collected and boiled for 5 min at 100 0 C. After separation on 6% SDS-PAGE, 14 the proteins were transferred onto nitrocellulose membrane for 4 hrs using TE 62 transfer unit (Amersham Pharmacia Biotech). Western blot analysis was performed as described above using affinity-purified specific polyclonal antibody directed against the C-terminus of human NMHC-IIB (Straussman et al., 2001 ). The western blots were developed using EZ 
Results
Phosphorylation of NMHC-IIB by PKC
We have previously shown that, both in vivo and in vitro, at least one PKC isoform is involved in the EGF-dependent NMHC-IIB phosphorylation in TSU-pr1 cells. TSU-pr1 cells express the PKC isoforms: βII, γ, ι, ζ and ε (Straussman et al., 2001) , of which βII and γ belong to the conventional PKC (cPKCs) (Newton, 2001) . We found that cPKCs, immunoprecipitated from TSU-pr1 cells stimulated with EGF using antibody raised against the hinge region of cPKCs, exhibited significant NMHC-IIB kinase activity (data not shown). To investigate whether these cPKCs can directly phosphorylate NMHC-IIB, we subjected recombinant PKCβII and PKCγ to an NMHC-IIB phosphorylation assay as described in Materials and Methods. Figure 3A shows that PKCγ, but not PKCβII, could phosphorylate
MHCBrod in vitro. To test whether PKCβII is active we used a common PKC substrate, MBP, as positive control. We fount that both PKC isoforms were capable of phosphorylating MBP to different extends indicating that PKCβII is active (Fig. 3B) . Although PKCβII had ~ 7
fold lower activity compared to PKCγ activity we would expect that if PKCβII was able to phosphorylate MHCBrod, this phosphorylation should have been above background (Fig. 3B) .
These results support the finding that PKCγ and not PKCβII phosphorylates MHCBrod. Since the molecular weight of PKCγ (80 kda) is close to the molecular weight of MHCBrod (70 kda), and members of the PKC family undergo autophosphorylation (Newton, 2001) , we wanted to make sure that the phosphorylation detected on MHCBrod is due to phosphorylation by PKCγ (Fig. 3A) and not to PKCγ autophosphorylation. For this purpose we subjected PKCγ to autophosphoryaltion assay, as shown in Figure 3C , 1952 ) of the full length of NMHC-IIB and at two additional serine residues lying in a cluster of four serine residues at positions 1935, 1938, 1939, 1941 of the full length of NMHC-IIB ( Fig. 4A and B ).
These serine residues are positioned on the non-helical tailpiece of NMHC-IIB, within a cluster of serine residues that was previously suggested by Murakami and colleagues as the potential phosphorylation sites for PKC using a mixture of α, β and γ cPKC isoforms (Murakami et al., 1998) .
To prove that the mapped residues are indeed the phosphorylation sites for PKCγ, we created MHCBrod-S6A construct with serine residues at positions 1937, 1952, 1935, 1938, 1939, 1941 converted to alanine residues (S6A, Fig. 1 ), as described in Materials and Methods, and subjected the resulting protein to a PKCγ phosphorylation assay. As shown in Figure 4C , the conversion of the PKCγ phosphorylation sites to alanine residues caused a marked decrease in MHCBrod-S6A phosphorylation by PKCγ, indicating that the mapped PKCγ phosphorylation sites on MHCBrod are the real sites in vitro.
As these sites were mapped in vitro, we wanted to verify their relevance for in vivo phosphorylation of NMHC-IIB. For this purpose we used COS-7 cells transiently transfected with NMHC-IIB or NMHC-IIB-S6A both tagged with GFP, and subjected them to in vivo phosphorylation assay as described in Materials and Methods. COS-7 cell line was chosen because it undergoes EGF-dependent cell motility (Jo et al., 2003) and has high transfection efficiency. As shown in Figure 4D , the ability of NMHC-IIB-S6A to undergo phosphorylation following EGF stimulation was markedly reduced resulting in ~45% decrease in phosphorylation compared to ~30% increase in NMHC-IIB phosphorylation. Thus it seems that the mapped PKCγ phosphorylation sites are relevant for NMHC-IIB phosphorylation in vivo. In addition, we presented evidence that the EGF-dependent NMHC-IIB phosphorylation that occurs in TSU-pr1 was also observed in COS-7 cells which may indicate that this is a general phenomenon. It should be noted that the peak of NMHC-IIB phosphorylation in TSUpr1 is 6 min after EGF stimulation }Straussman, 2001 #842}, while in Cos-7 cells the peak is at 2 min. Thus the EGF-dependent NMHC-IIB phosphorylation occurs in different cells with different kinetics.
NMHC-IIB co-localize with PKCγ in response to EGF stimulation
The results presented above indicate that PKCγ is involved in EGF-dependent NMHC-IIB phosphorylation, we therefore, investigated the dynamics of PKCγ and acto-NMHC-IIB cytoskeleton in TSU-pr1 cells stimulated with EGF. Cell motility signals like EGF initiate the formation of lamellipodial extension through massive actin polymerization at the cell's leading edge (Boonstra et al., 1995; Condeelis et al., 2001) . To determine whether a similar phenomenon exists in TSU-pr1 cells, we first followed the localization of acto-NMHC-IIB cytoskeleton in response to EGF stimulation using immunofluorescence staining with antibodies specific to the amino-terminus of NMHC-IIB (Ben-Ya'acov and Ravid, 2003) and rhodamine-phalloidin that recognizes specifically filamentous actin. Lamellipodial extensions observed after EGF stimulation were indeed accompanied by local disruption of cortical acto-NMHC-IIB margin-like structures reflected by extensive acto-NMHC-IIB co-localization (Fig.   5A ). NMHC-IIB density increased while actin filament density decreased along the lamellipodia from the tip towards the cell body (Fig. 5A ). This pattern of actin and NMHC-IIB localization is characteristic for lamellipodia (Verkhovsky and Borisy, 1993; Svitkina et al., 1997) .
To characterize the localization pattern of PKCγ in EGF-stimulated cells having lamellipodial extensions, we used cells transiently transfected with GFP-PKCγ. First we verified that the fusion protein GFP-PKCγ has activity properties characteristic of cPKC isoforms such as dependence on cofactors. For this purpose we transiently expressed GFP-PKCγ in HEK-293 cells, immunoprecipitated the GFP-PKCγ using GFP antibodies and subjected it to kinase assay as described in Materials and Methods. We found that addition of cofactors was essential for GFP-PKCγ activity indicating that the fusion of GFP to PKCγ did not affect its activity (data not shown), these results are consistent with previous reports (Sakai et al., 1997) . As shown in Figure 5B , GFP-PKCγ co-localized with NMHC-IIB at the cell cortex close to plasma membrane. In contrast GFP-PKCγ localized to the lamellipodia at the cell's leading edge, while NMHC-IIB was absent from this region. To verify that this pattern of GFP-PKCγ localization was not the result of overexpression we used indirect immunofluorescent staining of cells stimulated with EGF with antibody against the hinge region of cPKCs and antibody against NMHC-IIB (Fig. 5C ). In these cells, there is a marked enrichment of cPKCs in the lamellipodia at the cell's leading edge, as well as in the posterior region of the cell compare to the cytosolic region. It is therefore possible that the relatively high amount of GFP-PKCγ observed in the cytosolic region of cells expressing this kinase can be the result of GFP-PKCγ over-expression. Co-localization of cPKCs and NMHC-IIB in these cells was also mostly observed in the cell cortex close to the plasma membrane (Fig. 5C ).
Thus, in cells stimulated with EGF, PKCγ has an access to NMHC-IIB and via phosphorylation of NMHC-IIB it may affect the integrity of the acto-NMHC-IIB margin-like structures at the cell's leading edge as well as in posterior regions.
The effect of PKCγ over-expression on the actomyosin cytoskeleton, cell polarity and NMHC-IIB phosphorylation following EGF stimulation
To test the possibility that in TSU-pr1 cells, PKCγ can affect the integrity of acto-NMHC- 6A ).
To examine the effect of PKCγ WT and PKCγ DN expression on the acto-NMHC-IIB cytoskeleton, the stably expressing cell lines were stained for NMHC-IIB and F-actin using specific antibodies for NMHC-IIB and Rhodamin-phalloidin respectively. As shown in Figure   6B , GFP (control) (Fig. 6B) .
However, as PKC isoforms play a role in many biological processes that affect cytoskeleton, such as the regulation of actin polymerization (Keenan and Kelleher, 1998) and myosin light chain phosphorylation (Bresnick, 1999; Iwabu et al., 2004) , the effects we described above could be due to the role of PKCγ on these processes. (Murakami et al., 1984; Murakami et al., 1998; Straussman et al., 2001 ) may also phosphorylate NMHC-IIB. Another possibility is that the expressed PKCγ DN did not inhibit completely the activity of the endogenous PKCγ.
Over-expression of PKCγ WT reached a maximal level of NMHC-IIB phosphorylation similar to that in control cells (Fig. 7A) . However, the peak of NMHC-IIB phosphorylation in PKCγ WT cells appeared earlier than in control cells and remained up to 6 min after EGF stimulation, before declining (Fig. 7B) . This difference may be due to high amount of activated PKCγ WT followed EGF stimulation resulting in faster kinetics of NMHC-IIB phosphorylation with consequent disruption of acto-NMHC-IIB cytoskeleton.
The effect of the replacement of PKCγ sites by aspartate residues on NMHC-IIB localization Murakami et al. have shown that the critical concentration for NMHC-IIB fragment assembly being significantly higher for NMHC-IIB fragment with 4 PKC sites converted to aspartate residues compared to wild-type NMHC-IIB fragment (Murakami et al., 1998; Murakami et al., 2000) . To explore the possibility that the critical concentration for MHCBrod assembly is affected by PKCγ phosphorylation, we created a MHCBrod in which all 6
PKCγ phosphorylation sites were mutated to aspartate residues (S6D, Fig. 1 ). The MHCBrod-S6D protein also exhibited marked increase in the critical concentration for assembly compared to control wild type MHCBrod, 100 μg/ml and 15 μg/ml respectively.
To examine the in vivo effects of NMHC-IIB phosphorylation by PKCγ on its cellular localization, we created full-length NMHC-IIB fused to GFP in which the PKCγ phosphorylation sites were converted to aspartate residues (NMHC-IIB-S6D). We predicted that, if formation of acto-NMHC-IIB margin-like structures requires NMHC-IIB filament assembly and that phosphorylation of NMHC-IIB by PKCγ leads to local disassembly of these structures, then NMHC-IIB-S6D will exhibit lower assembly at the cell cortex compared to wild-type NMHC-IIB. To test this hypothesis we transiently transfected TSU-pr1 cells with wild type NMHC-IIB-WT or NMHC-IIB-S6D fused to GFP, stimulated the cells with EGF and monitored their localization as described in Materials and Methods. The level of NMHC-IIB expression in TSU-pr1 was about 1% of the endogenous NMHC-IIB (data not shown). It is possible that exogenous expression of NMHC-IIB in cells that express NMHC-IIB have some toxic effect leading to a low expression of the exogenous protein (Landsverk and Epstein, 2005) . While both NMHC-IIB-WT and NMHC-IIB-S6D were able to localize at the cell cortex, the amount of NMHC-IIB-S6D in the cell cortex seemed to be lower than that of NMHC-IIB-WT (Fig 8A) . To verify that localization of NMHC-IIB-WT to the cell cortex requires filament assembly, we expressed, in TSU-pr1 cells, NMHC-IIB with a deletion of 278 amino acids from the C-terminal region. This region contains the domains critical for filament assembly of NMHC-IIB (Nakasawa et al., 2005) . Figure 8A shows that this deletion abolished the cell cortical localization of this mutated NMHC-IIB. This result supports the idea that filament assembly is required for localization of NMHC-IIB to the cell cortex in EGFstimulated TSU-pr1 cells.
To quantify the amount of the expressed NMHC-IIB at the cell cortex, we developed a cortical index parameter that is the fraction of the cell cortex occupied by expressed NMHC- Since TSU-Pr1 cells express NMHC-IIB, the intracellular behavior of NMHC-IIB-S6D expressed in these cells can be affected by interaction with the endogenous NMHC-IIB, which can mask the real effect of NMHC-IIB phosphorylation. In addition, as mentioned above the level of NMHC-IIB expression in TSU-pr1 was about 1% of the endogenous NMHC-IIB.
Therefore, we transiently expressed NMHC-IIB and NMHC-IIB-S6D in cell line of mouse embryonic fibroblasts ablated for NMHC-IIB (Tullio et al., 1997) and subjected these cells to prolonged serum starvation which was previously shown to induce assembly of stress fibers (Giuliano and Taylor, 1990) , that are structures containing bipolar myosin II filaments (Langanger et al., 1986; Svitkina et al., 1989) . As shown in Figure 8C , it seems that NMHC-IIB-WT and NMHC-IIB-S6D have similar localization to the cell cortex and to stress fibers.
Since immunofluorescence technique is not quantitative, we determined the amount of expressed NMHC-IIB and NMHC-IIB-S6D that localizes with the cytoskeleton using Triton X-100 solubility assay as described in Materials and Methods. As shown in Figure 8D , the percent of insoluble NMHC-IIB-S6D was significantly lower than that of NMHC-IIB. Thus it seems that phosphorylation of NMHC-IIB by PKCγ inhibits its assembly presumably by 
Discussion
The acto-myosin II cytoskeleton plays an importance in cell motility (Lauffenburger and Horwitz, 1996; Mitchison and Cramer, 1996) . This was first demonstrated in the amoeba Dictyostelium discodeum; the polarity of cell movement was severely impaired in myosin II knockout cells, although general motility remained intact (Spudich, 1989) . Along with its participation in rear retraction, myosin II was thought to suppress lateral protrusive activities, allowing the cell to extend an actin-rich pseudopod exclusively from its leading edge, this establishes the polarity of movement.
In the present study we provide evidence for the involvement of PKCγ in the regulation of myosin IIB via heavy chain phosphorylation. We showed that PKCγ phosphorylates directly a 70 kDa C-terminal fragment and that PKCγ co-localized with NMHC-IIB in the cell cortex.
We further observed that protrusions at the cell's leading edge were enriched with actin and PKCγ , whereas NNMHC-IIB was absent from these regions. A similar pattern was observed using an antibody against cPKC isoforms. In addition, over-expression of PKCγ WT and PKCγ DN affected the dynamics of NMHC-IIB phosphorylation. Over-expression of PKCγ WT resulted in much faster kinetics of NMHC-IIB phosphorylation and disruption of proper organization of acto-NMHC-IIB cytoskeleton. This can be the result of the fast kinetics of PKCγ activation as recent report suggests that the mechanism of PKCγ activation differs from that of other members of cPKC in that that PKCγ can respond to diacylglycerol even without an increase in intracellular calcium (Ananthanarayanan et al., 2003) . A premature rise in NMHC-IIB phosphorylation in stimulated PKCγ WT cells can lead to premature disruption of acto-NMHC-IIB margin-like structures, leading to the formation of broad lamellipodia and multiple actin-rich protrusions (Fig. 6B ). In contrast, over-expression of PKCγ DN resulted in a significantly reduced level of NMHC-IIB phosphorylation with acto-NMHC-IIB cytosleleton remained intact even at the leading edge. Furthermore, expression of NMHC-IIB in which the PKCγ sites were converted to aspartate residues, thus mimicking the phosphorylation state of NMHC-IIB by PKCγ, caused a reduction in the amount of this mutated NMHC-IIB in the cell cortex in TSU-Pr1 cells and significant decrease in its localization to cell cytoskeleton in NMHC-IIB knockout fibroblasts. Thus, PKCγ phosphorylation of NMHC-IIB regulates its assembly presumably by decreasing its ability to form filaments.
Expression of PKCγ DN in TSU-pr1 cells did not inhibit the EGF-dependent NMHC-IIB phosphorylation completely (Fig 7A) suggesting that additional kinase(s) might be involved in NMHC-IIB phosphorylation. Resent studies from our laboratory suggest that the p21-activated kinase 1 (PAK1) is also involved in the regulation of NMHC-IIB phosphorylation (Even-Faitelson et al., 2005) and this regulation is mediated by aPKCζ that directly phosphorylates NMHC-IIB on a single serine residue about 1 min after EGF stimulation (Even-Faitelson L. and Ravid S., submitted). It is therefore plausible that the early phosphorylation of NMHC II-B by aPKCζ following EGF stimulation destabilizes the NMHC-IIB filaments and primes other phosphorylation events carried out by PKCγ.
Taken together, the results presented here allows us to propose a model for the regulation of NMHC-IIB through its heavy chain phosphorylation by PKCγ during cell migration (Fig. 9) .
In unstimulated cells, NMHC-IIB is mostly diffusely distributed within the cytosol (Straussman et al., 2001) . EGF stimulation results in translocation of NMHC-IIB to the cell cortex, where it associates with actin filaments to create acto-NMHC-IIB margin-like structures. At the same time there is an asymmetric activation of PLCγ resulting in a high concentration of cPKC lipid activators at the cell's leading edge (Chou et al., 2003) . This results in the preferential translocation of PKCγ to the membrane of the cell's leading edge and subsequent activation. NMHC-IIB in the cell cortex adjacent to the leading edge is exposed to the activated PKCγ, leading to its phosphorylation and to a local disruption of acto-NMHC-IIB margins at the leading edge. This enables the cell to extend actin-rich lamellipodia. The local 26 disruption of acto-NMHC-IIB can be mediated solely by activated PKCγ or by this together with additional signaling proteins. At the posterior region of the cell, acto-NMHC-IIB margins remain intact providing further support for cell polarity. When a cell translocates, it must retract its posterior part, requiring the disassembly of the acto-NMHC-IIB margins, which is achieved by NMHC-IIB phosphorylation. Our previous findings indicate that acto-NMHC-IIB margin disruption correlates with a peak of NMHC-IIB phosphorylation, increased Triton solubility, and its return to the cytosol (Straussman et al., 2001; Even-Faitelson et al., 2005) .
NMHC-IIB phosphorylation in this region can also be mediated directly by PKCγ or in concert with other kinase(s). Thus, our model suggests that the link between EGF receptor activation and transient NMHC-IIB phosphorylation is activation of PKCγ, as part of a general mechanism for establishing cell movement.
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Figure Legends 
